SG Americas Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26K Sell
41,000
-29,000
-41% -$2.98M ﹤0.01% 3077
2025
Q4
$15K Buy
70,000
+50,000
+250% +$5.04M ﹤0.01% 3484
2025
Q3
$4K Buy
+20,000
New +$2.14M ﹤0.01% 3335
2025
Q2
Sell
-35,400
Closed -$104K 2975
2025
Q1
$104K Sell
35,400
-38,200
-52% -$4.28M ﹤0.01% 3017
2024
Q4
$176K Hold
73,600
﹤0.01% 2268
2024
Q3
$276K Hold
73,600
﹤0.01% 2225
2024
Q2
$951K Sell
73,600
-14,600
-17% -$1.33M 0.01% 1324
2024
Q1
$975K Buy
88,200
+59,000
+202% +$5.66M ﹤0.01% 1146
2023
Q4
$682K Hold
29,200
0.01% 1270
2023
Q3
$624K Hold
29,200
0.01% 1596
2023
Q2
$711K Hold
29,200
0.01% 1230
2023
Q1
$552K Sell
29,200
-4,900
-14% -$673K 0.01% 1637
2022
Q4
$853K Buy
34,100
+31,600
+1,264% +$4.86M 0.01% 1087
2022
Q3
$205K Sell
2,500
-16,000
-86% -$2.45M ﹤0.01% 2306
2022
Q2
$1.3M Hold
18,500
0.01% 1069
2022
Q1
$1.22M Sell
18,500
-34,000
-65% -$5.71M 0.01% 1280
2021
Q4
$255K Sell
52,500
-9,300
-15% -$2.55M ﹤0.01% 2538
2021
Q3
$2.11M Buy
+61,800
New +$19.6M 0.01% 1219
2021
Q1
Sell
-53,900
Closed -$396K 3294
2020
Q4
$396K Buy
+53,900
New +$5.29M ﹤0.01% 2161

Other funds holding BNTX

SG Americas Securities's BNTX Position: Q1 2026 in Review

SG Americas Securities reduced its BioNTech (BNTX) stake by 26% in Q1 2026, selling an estimated $9.77M and leaving 270,245 shares worth $24M. The position accounts for 0.03% of the portfolio, ranked #477.

SG Americas Securities first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $45.5M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • SG Americas Securities held 270,245 shares of BioNTech worth $24M as of Q1 2026.
  • SG Americas Securities sold 95,088 BioNTech shares in Q1 2026, an estimated $9.77M.
  • BioNTech made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #477 holding.
  • SG Americas Securities first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
  • SG Americas Securities's BioNTech position peaked at $45.5M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.